Smallcap Eyecare Pharma Company Harrow Health Has Two Major Catalysts For 2025

Company Overview - Harrow Health is a founder-led eye health company with a market capitalization of approximately $1 billion [1] - The company has experienced strong growth in recent years, primarily due to strategic acquisitions [1] Stock Performance - The stock price of Harrow Health has seen a rise, but it is suggested that it may have become overvalued in 2024 [1] Investment Strategy - The focus is on value-oriented ideas and special situations, particularly in mid/small cap stocks [1] - There is an interest in orphaned and unfashionable investment ideas that have potential catalysts and asymmetric upside/downside payoffs [1] - The investment approach has shifted to being more influenced by momentum and quality compared to previous strategies [1]